The pivotal role of HDAC1 makes it an attractive therapeutic target, and HDAC inhibitors may inhibit tumor growth and metastasis by interfering with chromatin remodeling and gene expression regulation (46). The gene discussed is HDAC9; the disease is neoplasm.